18 children die after drinking cough syrup in Uzbekistan, Indian company accused

0
Dok-1 Max

New Delhi: After the deaths of 66 children in The Gambia, Uzbekistan’s health ministry has now blamed an Indian pharmaceutical company for the deaths of children in the country. Children in Uzbekistan have been claimed to have died after allegedly consuming cough syrup from an Indian pharmaceutical company. Uzbekistan’s health ministry has alleged that 18 children died in their country after consuming drugs manufactured by an Indian pharmaceutical company. happened.

According to Uzbekistan’s local news website, AKI.com, the tablet and syrup, Dok-1 Max, which were manufactured by Uttar Pradesh-based Marion Biotech, is reportedly responsible for the deaths of several children in the former Soviet colony. The report also states that these children were admitted to the hospital with acute respiratory diseases.

The report claimed that children died after consuming Dok-1 Max syrup manufactured by pharmaceutical company Marion Biotech, the ministry said in a statement. The pharmaceutical company entered the Uzbekistan market in the year 2012. According to the sources, Dok-1 Max syrup manufactured by this company is currently not being sold in the Indian market.

In its statement, the Uzbekistan health ministry said that the children who died took 2.5 milliliters to 5 milliliters of the cough syrup at home three to four times a day, which was higher than the standard dose of the drug.

After the deaths, tablets and cough syrups of Dok 1 have been withdrawn from sale in all pharmacies of the country, the statement said.

Dok-1 Max

66 children died in Gambia
Significantly, in the Gambia last October, 66 children died due to cough syrup made in India. The African country alleged that 66 children had died in their country after consuming syrup made in India. However, this has not been confirmed yet.

At the same time, taking the matter seriously, the Central Government formed a committee to investigate. This committee was formed under the chairmanship of Dr. YK Gupta, Vice Chairman of the Standing National Committee on Medicine. After the formation of the committee, the production of the pharmaceutical company was stopped till the investigation report came. The committee inspected the place where this syrup was being produced. The committee collected the samples and sent them to the lab in Chandigarh.

Advertisement